Literature DB >> 4199414

The subunit structure of normal and hemophilic factor VIII.

G A Shapiro, J C Andersen, S V Pizzo, P A McKee.   

Abstract

Human factor VIII from normals and hemophiliacs was partially purified by ethanol and polyethylene glycol precipitations. Final purification was achieved by gel filtration on 2 or 4% agarose or ion exchange chromatography on diethylaminoethyl cellulose. Comparable amounts of highly purified protein were obtained from normal and hemophilic plasma following the agarose chromatography step. Highly purified factor VIII was not dissociated by 6 M guanidine hydrochloride or 1% sodium dodecyl sulfate. However, when reduced by beta-mercaptoethanol and analyzed by sodium dodecyl sulfate polyacrylamide gel electrophoresis, a single subunit species with an estimated 195,000 molecular weight was found for both normal and hemophilic factor VIII. By sedimentation equilibrium analysis, the normal factor VIII subunit was homogeneous and had an estimated molecular weight of 202,000. The subunit polypeptides from normal or hemophilic factor VIII contained carbohydrate. Each was homogeneous by isoelectric focusing. Immunodiffusion of purified normal and hemophilic factor VIII against rabbit antiserum to purified normal human factor VIII showed a single line of precipitation. Very low concentrations of purified human thrombin initially increased the activity of normal factor VIII about threefold and then progressively destroyed activity by 3 h. Only minimal activation occurred with hemophilic factor VIII. Both the activation and inactivation of normal and hemophilic factor VIII were unaccompanied by detectable changes in subunit molecular weight. These findings may have implications for the definition of the molecular defect in hemophilic factor VIII.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4199414      PMCID: PMC333021          DOI: 10.1172/JCI107405

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  31 in total

1.  THE MOLECULAR WEIGHT OF THE POLYPEPTIDE CHAINS OF L-GLUTAMATE DEHYDROGENASE.

Authors:  E MARLER; C TANFORD
Journal:  J Biol Chem       Date:  1964-12       Impact factor: 5.157

2.  Microheterogeneity of L-amino acid oxidase. Separation of multiple components by polyacrylamide gel electrofucusing.

Authors:  M B Hayes; D Wellner
Journal:  J Biol Chem       Date:  1969-12-25       Impact factor: 5.157

3.  Glycoprotein staining following electrophoresis on acrylamide gels.

Authors:  R M Zacharius; T E Zell; J H Morrison; J J Woodlock
Journal:  Anal Biochem       Date:  1969-07       Impact factor: 3.365

4.  Immunologic studies of antihemophilic factor (AHF, factor VIII): cross-reacting material in a genetic variant of hemophilia A.

Authors:  L W Hoyer; R T Breckenridge
Journal:  Blood       Date:  1968-12       Impact factor: 22.113

5.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

6.  The estimation of polypeptide chain molecular weights by gel filtration in 6 M guanidine hydrochloride.

Authors:  W W Fish; K G Mann; C Tanford
Journal:  J Biol Chem       Date:  1969-09-25       Impact factor: 5.157

7.  A clinical and experimental study of acquired inhibitors to factor 8.

Authors:  H R Roberts; M B Scales; J T Madison; W P Webster; G D Penick
Journal:  Blood       Date:  1965-12       Impact factor: 22.113

8.  Isopiestic compositions as a measure of preferential interactions of macromolecules in two-component solvents. Application to proteins in concentrated aqueous cesium chloride and guanidine hydrochloride.

Authors:  E P Hade; C Tanford
Journal:  J Am Chem Soc       Date:  1967-09-13       Impact factor: 15.419

9.  Studies on the purification of antihemophilic factor (factor 8. I. Precipitation of antihemophilic factor by concanavalin A.

Authors:  L Kass; O D Ratnoff; M A Leon
Journal:  J Clin Invest       Date:  1969-02       Impact factor: 14.808

10.  Studies on the purification of antihemophilic factor (factor VIII). II. Separation of partially purified antihemophilic factor by gel filtration of plasma.

Authors:  O D Ratnoff; L Kass; P D Lang
Journal:  J Clin Invest       Date:  1969-05       Impact factor: 14.808

View more
  19 in total

1.  Effects of thrombin treatment of preparations of factor VIII and the Ca2+-dissociated small active fragment.

Authors:  H A Cooper; F F Reisner; M Hall; R H Wagner
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

2.  Studies on human antihemophilic factor. Evidence for a covalently linked subunit structure.

Authors:  M E Switzer; P A McKee
Journal:  J Clin Invest       Date:  1976-04       Impact factor: 14.808

3.  Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets.

Authors:  K J Kao; S V Pizzo; P A McKee
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

4.  Subunit structure and assembly of von Willebrand factor polymer: complementary analysis by electron microscopy and quasielastic light scattering.

Authors:  J Loscalzo; H Slayter; R I Handin; D Farber
Journal:  Biophys J       Date:  1986-01       Impact factor: 4.033

5.  Effect of phospholipases on factor-VIII activity.

Authors:  R Ananthakrishnan; S D'Souza
Journal:  Hum Genet       Date:  1978-01-19       Impact factor: 4.132

6.  Macromolecular factor VIII complex: functional and structural heterogeneity observed in von Willebrand swine with transfusion.

Authors:  T R Griggs; J S Potter; S B McClanahan; W P Webster; K M Brinkhous
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

7.  Disulfide bonds and the quaternary structure of factor VIII/von Willebrand factor.

Authors:  R B Counts; S L Paskell; S K Elgee
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

8.  Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.

Authors:  Z M Ruggeri; T S Zimmerman
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

9.  Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.

Authors:  K J Kao; S V Pizzo; P A McKee
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

10.  [A variant of the von Willebrand-Jürgens-syndrome with abnormalities of the factor VIII/von Willebrand factor protein (author's transl)].

Authors:  K Hasler; D Böttcher; R Engelhardt
Journal:  Blut       Date:  1979-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.